11.01.2011
- Shares in Swiss drugs industry supplier Lonza fell over 4% on Monday after Deutsche Bank analysts downgraded the stock as they expect the strong Swiss franc and a tougher...
10.01.2011
- The strong Swiss franc will be a major challenge for the Swiss economy in the next five years, Lonza Chief Executive Stefan Borgas was quoted as saying in a newspaper interview on...
22.11.2010
- European regulators adopted a new guideline on so-called biosimilar antibody drugs on Friday, paving the way for cheaper copies of multi-billion-dollar medicines for cancer and...
08.09.2010
- Swiss drugs industry supplier Lonza will manufacture a number of drug compounds for Britain's Glaxosmithkline, in a sign demand for the Swiss group's products is recovering. Lonza...
30.08.2010
- Lonza enters the viral based-manufacturing market today with its purchase of Vivante GMP Solutions. The acquisition advances Lonza's strategy to broaden its biologics custom...
22.07.2010
- Lonza has announced sales of CHF 1,301 million for H1 2010, which was similar level to H1 2009 (-2.1%). The company said this was due to an expectedly weak first quarter in custom...
27.05.2010
- Europe's economic jitters will clean out the health-science industry, leaving global generic as well as innovative drugmakers among the survivors, the head of Swiss drugmaker Roche...
26.05.2010
- Israel's Teva Pharmaceutical Industries is developing a generic version of Roche's blockbuster antibody drug Rituxan, highlighting the race to produce so-called biosimilar...
